Kids with refractory or relapsed high-risk neuroblastoma cancer who were treated with 131I-metaiodobenzylguanidine (131I-MIBG) had a favorable prognosis, reveals a new study.
from Medindia Health News https://ift.tt/3dgNIwP
Saturday, 20 June 2020
Novel Radioisotope Therapy may Provide Favorable Prognosis in Kids with High-risk Neuroblastoma
Kids with refractory or relapsed high-risk neuroblastoma cancer who were treated with 131I-metaiodobenzylguanidine (131I-MIBG) had a favorable prognosis, reveals a new study.
from Medindia Health News https://ift.tt/3dgNIwP
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment